AU785230B2 - Egg and feed ration for producing egg - Google Patents
Egg and feed ration for producing egg Download PDFInfo
- Publication number
- AU785230B2 AU785230B2 AU45772/02A AU4577202A AU785230B2 AU 785230 B2 AU785230 B2 AU 785230B2 AU 45772/02 A AU45772/02 A AU 45772/02A AU 4577202 A AU4577202 A AU 4577202A AU 785230 B2 AU785230 B2 AU 785230B2
- Authority
- AU
- Australia
- Prior art keywords
- egg
- vitamin
- serve
- feed ration
- speci
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 235000013601 eggs Nutrition 0.000 claims description 37
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 12
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims description 12
- 241000894007 species Species 0.000 claims description 12
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 11
- 239000011701 zinc Substances 0.000 claims description 10
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 9
- 229910052725 zinc Inorganic materials 0.000 claims description 9
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 8
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- 241000271566 Aves Species 0.000 claims description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 229940090949 docosahexaenoic acid Drugs 0.000 claims description 6
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 5
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 5
- 229930003316 Vitamin D Natural products 0.000 claims description 5
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 5
- 229930003448 Vitamin K Natural products 0.000 claims description 5
- 210000000991 chicken egg Anatomy 0.000 claims description 5
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 5
- 235000021003 saturated fats Nutrition 0.000 claims description 5
- 229910052711 selenium Inorganic materials 0.000 claims description 5
- 239000011669 selenium Substances 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 5
- 235000019165 vitamin E Nutrition 0.000 claims description 5
- 239000011709 vitamin E Substances 0.000 claims description 5
- 235000019168 vitamin K Nutrition 0.000 claims description 5
- 239000011712 vitamin K Substances 0.000 claims description 5
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 5
- 229940046008 vitamin d Drugs 0.000 claims description 5
- 229940046010 vitamin k Drugs 0.000 claims description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 4
- 229930003427 Vitamin E Natural products 0.000 claims description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 4
- 229910052740 iodine Inorganic materials 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 229940055726 pantothenic acid Drugs 0.000 claims description 4
- 235000019161 pantothenic acid Nutrition 0.000 claims description 4
- 239000011713 pantothenic acid Substances 0.000 claims description 4
- 229960002477 riboflavin Drugs 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 229940046009 vitamin E Drugs 0.000 claims description 4
- 229940045997 vitamin a Drugs 0.000 claims description 4
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 claims description 3
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 235000019743 Choline chloride Nutrition 0.000 claims description 3
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 3
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 241000219745 Lupinus Species 0.000 claims description 3
- 229930003779 Vitamin B12 Natural products 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- 229960003178 choline chloride Drugs 0.000 claims description 3
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 3
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 claims description 3
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 3
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 3
- 235000004426 flaxseed Nutrition 0.000 claims description 3
- 229940014144 folate Drugs 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 239000011630 iodine Substances 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 3
- 229960003495 thiamine Drugs 0.000 claims description 3
- 235000019163 vitamin B12 Nutrition 0.000 claims description 3
- 239000011715 vitamin B12 Substances 0.000 claims description 3
- 229930003451 Vitamin B1 Natural products 0.000 claims description 2
- 229930003471 Vitamin B2 Natural products 0.000 claims description 2
- 235000021084 monounsaturated fats Nutrition 0.000 claims description 2
- 235000021085 polyunsaturated fats Nutrition 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- 235000010374 vitamin B1 Nutrition 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims description 2
- 235000019164 vitamin B2 Nutrition 0.000 claims description 2
- 239000011716 vitamin B2 Substances 0.000 claims description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- 210000002969 egg yolk Anatomy 0.000 description 15
- 235000012000 cholesterol Nutrition 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 229940088594 vitamin Drugs 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 7
- 235000013343 vitamin Nutrition 0.000 description 7
- 239000011782 vitamin Substances 0.000 description 7
- 201000010099 disease Diseases 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 4
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 229960000304 folic acid Drugs 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000011572 manganese Substances 0.000 description 4
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000001079 digestive effect Effects 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 208000005623 Carcinogenesis Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010022489 Insulin Resistance Diseases 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000567 anti-anemic effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000036952 cancer formation Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 231100000504 carcinogenesis Toxicity 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000036449 good health Effects 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 235000019192 riboflavin Nutrition 0.000 description 2
- 239000002151 riboflavin Substances 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical group 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 208000027244 Dysbiosis Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 108010014173 Factor X Proteins 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000234609 Portulaca oleracea Species 0.000 description 1
- 235000001855 Portulaca oleracea Nutrition 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 206010047634 Vitamin K deficiency Diseases 0.000 description 1
- 235000021068 Western diet Nutrition 0.000 description 1
- BTOLIPYANIYAQR-UHFFFAOYSA-N [B].[Cr].[Se].[Co].[I].[Fe] Chemical compound [B].[Cr].[Se].[Co].[I].[Fe] BTOLIPYANIYAQR-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000008047 antioxidant nutrient Substances 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 235000012721 chromium Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000034653 disorder of pilosebaceous unit Diseases 0.000 description 1
- 230000007140 dysbiosis Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000000497 foam cell Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000013016 learning Effects 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 229910000357 manganese(II) sulfate Inorganic materials 0.000 description 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 1
- 230000003818 metabolic dysfunction Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000011785 micronutrient Substances 0.000 description 1
- 235000013369 micronutrients Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000026721 nail disease Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 208000035581 susceptibility to neural tube defects Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Description
I I
AUSTRALIA
Patents Act 1990 COMPLETE SPECIFICATION STANDARD PATENT Applicant: FARM PRIDE FOODS LTD Invention Title: EGG AND FEED RATION FOR PRODUCING EGG The following statement is a full description of this invention, including the best method of performing it known to me: 2 EGG FEED RATION FOR PRODUCING EGG This invention relates to an egg and, in particular, to a chicken egg, and to a feed ration, which can be fed to egg laying birds, for producing the egg.
As is well known, chicken eggs are a common source of food and provide many vitamins, minerals and other substance required and essential in a persons diet.
Conventional chicken eggs also can be high in saturated fats and other substances which are not as beneficial to a consumer.
The object of this invention is to provide an egg which has improved nutritional characteristics.
The invention, in a first aspect, may be said to reside in a chicken egg comprising; Sthe following substances per 100g serve of the egg; iodine 30g to 150pg; selenium 15pg to zinc 1.0mg to iron 1.8mg to Vitamin E 2mg to Vitamin A 150pg to 400pg; 30 Vitamin B1 0.1mg to 0.35mg; Vitamin B2 0.4mg to 0.9mg; Vitamin B12 1.0g to Vitamin D 2.4gg to 8g; Folate 50gg to 120g; Omega3 700mg to 1500mg; Pantothenic Acid 1.2mg to Biotin 7.Og to H:\Luial\Keep\Speci\Farm Price 45772-02.doc 18/08/06 3 Omega6 1000mg to 2000mg; DHA (docosahexaenoic acid) 80mg to 350mg; and Vitamin K 8ig to Preferably the Omega 6 to Omega 3 ratio is 1.5:1.
Preferably saturated fats form no more than 28% of the total fat content of the egg.
Preferably the polyunsaturated fat is greater than per 100g serve.
Preferably the mono unsaturated fat is greater than per 100g serve.
Preferably the saturated fat content is less than 2.80g per 100g serve.
The invention also provides a vegetarian feed ration for birds for producing eggs for human consumption, comprising: INGREDIENT BY WT Wheat 39.549 Triticali Lupins 29% Extracted Soya 48% 20.5 Oil (Flaxseed) Limegrit 9.2 Salt 0.25 Sodium Bicarbonate 0.20 Dicalcium Phosphate 1.7 D L Methionine 0.19 Choline Chloride 0.15 Enzyme (Allzyme PT) 0.07 Tryptosine 15/70 0.1 H.\Luiea1\Keep\Speci\Parm Price 4S772-02.doc 18/08/06 4 Sea Plant (DHA Gold) 0.25 Premix B 0.65 Y. Colour Red 0.165 Y. Colour Yellow 0.026 TOTAL 100 and wherein premix B is in accordance with Example 2 described in this specification.
The invention also includes an egg produced by a bind fed with a feed ration as described above.
Preferred embodiments of the invention will be described, by way of example, with reference to the following
S
S..
S THE NEXT PAGE IS PAGE 6 H.\Luisal\Keep\Speci\Farm Price 45772-02.doc 18/08/06 -6 examples.
Most preferably the egg includes the following; Presence Per 100gm of edible egg Yolk Fat Poly Mono 4.Og Saturated 2.8g Yolk Pantothenic Acid Yolk Omega 3 1200mg Omega 6 1450mg Yolk Cholesterol/100g 380mg Yolk Vitamin A 280jig (Retinol) Yolk Vitamin E (o0c Tocopherol) Yolk Thiamin (El) 0.11mg White/Yo Riboflavin B2 1k Yolk Folate Yolk Vitamin B12 1.312g Yolk Iron 1.8mg Yolk zinc 1.2mg _______Selenium Yolk Biotin 12g Yolk Iodine lOgg Yolk Vitamin D Yolk DHA 200mg Vitamin K 8mg mg= milligrams jpg=- micrograms Examples of the feed ration according to the preferred embodiments of the invention are set out in the following table.
H: \abourke\Keep\Speci \EGG FEEOSTOCK FOR PRODUCING EGG FAP14 PRIDEdoc 3/06/02 -7 Example 1 Example 2 PREMIX A PREMIX B Premix Source Inorganic Organic Total Inorganic Organic Total Components Typical Vitamin Units Premix Vitamin A iu/kg 15 2 Vitamin D iu/kg 7 7 Vitamin E mg/kg 150 150 2 Vitamin K3 mg/kg 5 6.3 2 Thiamine B1 mg/kg 6 6 Riboflavin B2 mg/kg 15 16.5 Pyridoxine B6 mg/kg 18 18 0.01 Cobalami B12 mg/kg 0.04 0.04 n Niacin mg/kg 100 0.75 Folic Acid mg/kg 3 Pantothenic mg/kg 45 Acid H:\mbourke\Keep\Speci\EGG FEEDSTOCK FOR PRODUCING EGG FARM PRIDE.doc 3/06/02 8- Example 1 (Continued) Example 2 (Continued) PREMIX A PREMIX
B
r 4 Premix Components Minerals Zinc Zn Manganes Mn e Copper Cu Source mg/kg mg/kg mg/kg mg/kg mg/kg mg/kg pp~m ppb Inorganic Organic Iron Iodine Cobalt Selenium Chromium Boron Antioxidant 120 ZnSO4 120 MnSO4 185 CuSO4 70 FeSO4 3 Ca Iodate 1.5 Co Suiph 0.3 Sod Selenate 0.1 Sod Borate 20 BP Zinc 20 BP Mang 15
BP
Copper 0.25 Selplex 800 Biochrom e Total 140 140 200 70 3 1.5 0.55 800 0.1 150 g 135 35 ZnSO4 BP Zinc 120 20 Mn S04 BP Mang 20 10 CuSO4 BP Copper 70 FeSO4 3 Ca Iodate 1.5 Co Suiph 0.3 0.25 Sod Selenate Seiplex 200 Biochrom e 0.1 Sod Borate Inorganic Organic Total 170 140 3 0.55 200 0.1 150 g A J I H: \ob0rke\Keep\SpeCi \EGG FEEDSTOCK FOR PRODUCING EGG FARM4 PRIDEdoc 3/06/02 9 The premixes according to the above examples are further mixed with additional components to form the entire diet to be fed to the birds. One example of the entire diet using premix B, which is Example 2 mentioned above, and which is the preferred feed ration, is as follows: INGREDIENT BY WT Wheat 39.549 Triticali Lupins 29% Extracted Soya 48% 20.5 Oil (Flaxseed) Limegrit 9.2 Salt 0.25 Sodium Bicarbonate 0.20 Dicalcium Phosphate 1.7 D L Methionine 0.19 Choline Chloride 0.15 Enzyme (Allzyme PT) 0.07 Tryptosine 15/70 0.1 Sea Plant (DHA Gold) 0.25 Premix B 0.65 Y. Colour Red 0.165 Y. Colour Yellow 0.026 TOTAL 100 The nutritional improvements which the egg and feed ration according to the preferred embodiment of the invention can provide are as follows; 1. Folic Acid: involved in DNA/RNA synthesis, Red blood cell formation, and has an Anti-anemic effect. This vitamin has been shown to decrease the incidence of neural tube defects by when suplemented to women before becoming pregnant.
H: \rbourke\Keep\Speci\EGG FEEDSTOCK FOR PRODUCING EGG FARM PP.IDE.doc 3106/02 10 2. Folic Acid and B12: involved synergistically in red blood cell production and have anti-anemic effects. Both are involved in improving energy levels, metabolic efficiency and appetite. Both vitamins can be deficient in sports people, elderly, sick people and women because of blood loss.
3. Homocysteine Reduction and Control: homocysteine is an amino acid which has been shown to be high in people suffering from and dying from heart disease and atherosclorosis. This disposition appears to be genetically inherited and is made worse by a deficiency of B12 and folic acid.
These vitamins help homocysteine to be recycled back into methionine again. Homocysteine metabolism and control maybe more important in the aetiology of these diseases than cholesterol. These critical vitamins have been enriched in Vitaegg.
4. Cholesterol Metabolism and Importance to Health Cholesterol is essential to human health being a precursor to all sex hormones, vitamin D and bile acids. It is essential for fertility and too little cholesterol causes increases in stroke, cancer and violent deaths (suicide etc). Intervention trials aimed at reducing cholesterol to monitor effects on CHD/CVD and mortality showed that cholesterol and mortality due to these diseases was reduced but that total mortality was not. There was a rise in mortality due to the other diseases and factors described above.
The real problem with cholesterol is when it oxidises to form oxycholesterol. This is the start of the formation H:\mbourke\Keep\Speci\EGG FEEDSTOCK FOR PRODUCING EGG FARM PRIDE.doc 3/06/02 11 of foam cells and calcified plaques on artery walls that end up blocking the artery leading to heart and cardiovascular failure.
Too much LDL and not enough HDL, which scrubs the artery of this plaque and carries it back to the liver for processing, also exacerbates the problem.
The solution to these problems is to provide adequate antioxidant nutrients to improve antioxidant status.
These include: vitamins E, D, A and minerals Se, Zn, Mn, I and Cu.
Increasing HDL and lowering LDL is achieved by increasing chromium, niacin, B vitamins, flaxseed oil, omega 3 and by use of Purslane and Bio-Mos (mannanoligosaccharide).
Diabetes: This is an increasing problem due to poor lifestyle factors, genetic risk, lack of exercise, obesity, poor carbohydrate and fat metabolism problems, insulin resistance (factor X syndrome) and inadequate antioxidant status.
Factors known to control this disease including eliminating insulin injections are: 1. increasing general antioxidant status to reduce the oxidative stress suffered by diabetics (most vitamins, Se, Zn, Cu, Mn).
2. increasing zinc, omega 3 are highly specific to controlling this preventable disease.
Digestive disorders, stress, liver disease, poor detoxification function, poor cognitive function, learning, behavioral difficulties and crime, depression dementia, can be either controlled, reversed or eliminated with the array of nutrients levels incorporated into the egg.
H: \mbourke\Keep\Speei\EG L FEEDS7 OCK FOR PRODUCING EGG FARM PRIDE~doc 3/06/02 12 These conditions are becoming increasingly more common.
Many of these problems are due to nutrient deficiencies and metabolic dysfunctions especially where lifestyle, toxic loads, emotional environment are not conducive to good health and hence the requirements for most nutrients are raised in order to support optimum health.
Pantothenic acid is involved in stress response, adrenal glands digestive disorders, digestive acid production, stress hormone production and response, psychological state among others. Every micronutrient discussed is involved directly or as co-factors in biochemical process that control these conditions.
The importance of the constituents of eggs produced according to the preferred embodiment of the invention, and also produced by birds which are fed with the feed stock according to the preferred embodiment of the invention, are as follows: 1. Omega 3: Essential long chain fatty acids important in controlling carcinogenesis, cardiac function, inflammation, brain composition and function, skin condition, cell membranes, cell proliferation, insulin sensitivity, weight control and many biochemical reactions. Omega 3 is useful for reducing cholesterol levels and blood clotting risk, preventing arthritis and various nervous and neuronal conditions; 2. DHA: An essential nutrient in brain composition and cognitive function, cell membranes, cardiac composition and function, preventing of myocardial infarction/coronary heart disease.
3. Omega 6 to Omega 3 Ratio: The balance between these essential amino acids is important. Current diets H: \mbourke\Xeep\Spec1\G PEEDSTOCX FOR PRODUCING EGG Fin PRIDE.doc 3/06/02 13 have high omega 6 to omega 3 ratios which are nonoptimum for good health. High omega 6 and low omega 3 ratios promote inflammatory processes in the body and are correlated with higher risk of carcinogenesis occurring. Low levels of omega 3 are generally found in the typical Western diet which has exacerbated this unfavourable ratio.
4. Vitamin K: Vitamin K is required for normal blood clotting processes through Prothrombin production.
Bleeding can be caused by vitamin K deficiencies.
Infants can exhibit abnormal growth if deficient.
Biotin: Biotin is essential for normal growth, development and health. Deficiency symptoms include skin, nail and hair disorders, fatigue, depression, nausea, loss of appetite, muscular pains, elevated blood cholesterol, anaemia and faulty fat, carbohydrate and protein metabolism. Dysfunctional and dysbiosis of intestinal microflora cause reduced biotin production in many people.
Since modifications within the spirit and scope of the invention may readily be effected by persons skilled within the art, it is to be understood that this invention is not limited to the particular embodiment described by way of example hereinabove.
In the claims which follow and in the preceding 30 description of the invention, except where the context i. requires otherwise due to express language or necessary 0 0 implication, the word "comprise", or variations such as "comprises" or "comprising", is used in an inclusive sense, i.e. to specify the presence of the stated features but not to preclude the presence or addition of further features in various embodiments of the invention.
HI\Luisal\Keep\Speci\Farm Price 45772-02.doc 18/08/06
Claims (6)
1. A chicken egg comprising: the following substances per 100g serve of the egg; iodine 30g to 150gg; selenium 15pg to zinc 1.0mg to iron 1.8mg to 0 Vitamin E 2mg to Vitamin A 150g to 400gg; Vitamin B1 0.1mg to 0.35mg; Vitamin B2 0.4mg to 0.9mg; Vitamin B12 1.0pg to Vitamin D 2.4gg to 8gg; Folate 50gg to 120gg; Omega3 700mg to 1500mg; Pantothenic Acid 1.2mg to Biotin 7.0ig to 0 Omega6 1000mg to 2000mg; DHA (docosahexaenoic acid) 80mg to 350mg; and Vitamin K 8ug to 0* 00 0 0 0000 0 00*0 0000 00 0 0*0. 0 00 0
2. 3 ratio The egg of claim 1, wherein the Omega 6 to Omega is 1.5:1.
3. The egg of any one of claims 1 or 2, wherein saturated fats form no more than 30% of the total fat content of the egg.
4. The egg of any one of claims 1 to 3, wherein polyunsaturated fat is greater than 2.5g per 100g serve. The egg of any one of claims 1 to 4, wherein mono unsaturated fat is greater than 4.0g per 100g serve. The egg of claim 3, wherein the saturated fat h.\Luisa1\Keep\Speci\Farm Price 45772-02.doc 18/08/06 15 S S S 5*55 S *5 S S. S content is less than 2.80g per 100g serve.
7. A vegetarian feed ration for birds for producing eggs for human consumption, comprising: INGREDIENT BY WT Wheat 39.549 Triticali Lupins 29% Extracted Soya 48% 20.5 Oil (Flaxseed) Limegrit 9.2 Salt 0.25 Sodium Bicarbonate 0.20 Dicalcium Phosphate 1.7 D L Methionine 0.19 Choline Chloride 0.15 Enzyme (Allzyme PT) 0.07 Tryptosine 15/70 0.1 Sea Plant (DHA Gold) 0.25 Premix B 0.65 Y. Colour Red 0.165 Y. Colour Yellow 0.026 TOTAL 100 and wherein premix B is in accordance with Example 2 described in this specification. 10 8. A chicken egg, substantially as hereinbefore described with reference to the example given in the specification.
9. A vegetarian feed ration for feeding to birds which produce eggs for human consumption, substantially as hereinbefore described with reference to the accompanying examples. H.\LUi8a1\Keep\Speci\Fal Price 45772-02.doc 18/08/06 16 A chicken egg produced by a bird fed with a feed ration according to claim 7. Dated this 18th day of August 2006 FARM PRIDE By their Patent Attorneys GRIFFITH HACK Fellows Institute of Patent and Trade Mark Attorneys of Australia so.. .0 so* so* H.\LUisal\Keep\Speci\Farm Price 45172-02 .doc 18/08/06
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU45772/02A AU785230B2 (en) | 2001-06-14 | 2002-06-03 | Egg and feed ration for producing egg |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPR5672A AUPR567201A0 (en) | 2001-06-14 | 2001-06-14 | Egg and feed ration for producing egg |
| AUPR5672 | 2001-06-14 | ||
| AU45772/02A AU785230B2 (en) | 2001-06-14 | 2002-06-03 | Egg and feed ration for producing egg |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4577202A AU4577202A (en) | 2002-12-19 |
| AU785230B2 true AU785230B2 (en) | 2006-11-23 |
Family
ID=32714036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU45772/02A Ceased AU785230B2 (en) | 2001-06-14 | 2002-06-03 | Egg and feed ration for producing egg |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU785230B2 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105494261A (en) * | 2015-12-30 | 2016-04-20 | 天津市寿南山禽蛋营养研发有限公司 | Method and nutrient for producing DHA (Docosahexaenoic Acid) and zinc-rich eggs |
| CN105532574A (en) * | 2015-12-30 | 2016-05-04 | 天津市寿南山禽蛋营养研发有限公司 | Production method of eggs rich in DHA and iron elements and nutritional agent |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102972336A (en) * | 2011-09-05 | 2013-03-20 | 敖汉远绿生态农牧业科技有限公司 | Breeding method of laying hens capable of laying high selenium eggs |
| CN102696869B (en) * | 2012-06-13 | 2015-03-11 | 大连韩伟养鸡有限公司 | Production method for eggs rich in DHA and Vitamin E ingredients |
| EP3348149A1 (en) * | 2017-01-16 | 2018-07-18 | AG Mailwald A.S. | Consumer shell egg |
| CN107518147A (en) * | 2017-09-19 | 2017-12-29 | 湖南七纬科技有限公司 | A kind of method that selenoprotein is extracted from Se-enriched egg |
| RU2687532C1 (en) * | 2018-06-13 | 2019-05-14 | Федеральное государственное бюджетное научное учреждение Федеральный научный центр "Всероссийский научно-исследовательский и технологический институт птицеводства" Российской академии наук | Method for production of food eggs for dietary and functional feeding with adjusted lipid profile |
| CN110447772A (en) * | 2019-09-11 | 2019-11-15 | 广西鸿光农牧有限公司 | A kind of laying cycle of laying hens silty mixed feed and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4918104A (en) * | 1987-06-16 | 1990-04-17 | Weiss Howard S | Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom |
| US5246717A (en) * | 1991-10-31 | 1993-09-21 | C. R. Eggs Inc. | Eggs compatible with cholesterol-reducing diet and method of producing the same |
| WO2001030180A1 (en) * | 1999-10-26 | 2001-05-03 | Liferight Foods, L.L.C. | Poultry egg with beneficial health and nutritive values |
-
2002
- 2002-06-03 AU AU45772/02A patent/AU785230B2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4918104A (en) * | 1987-06-16 | 1990-04-17 | Weiss Howard S | Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom |
| US5246717A (en) * | 1991-10-31 | 1993-09-21 | C. R. Eggs Inc. | Eggs compatible with cholesterol-reducing diet and method of producing the same |
| WO2001030180A1 (en) * | 1999-10-26 | 2001-05-03 | Liferight Foods, L.L.C. | Poultry egg with beneficial health and nutritive values |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105494261A (en) * | 2015-12-30 | 2016-04-20 | 天津市寿南山禽蛋营养研发有限公司 | Method and nutrient for producing DHA (Docosahexaenoic Acid) and zinc-rich eggs |
| CN105532574A (en) * | 2015-12-30 | 2016-05-04 | 天津市寿南山禽蛋营养研发有限公司 | Production method of eggs rich in DHA and iron elements and nutritional agent |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4577202A (en) | 2002-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Oestreicher et al. | Copper and zinc absorption in the rat: mechanism of mutual antagonism | |
| Friedrich | Vitamins | |
| Tanumihardjo et al. | Provitamin A carotenoid bioavailability: what really matters? | |
| Jan et al. | Vitamin D fortification of foods in India: present and past scenario | |
| WO2000012080A1 (en) | Diet composition and method of weight management | |
| CA2747753C (en) | Nutritional supplements for 50+ individuals for improving vitality, immunity, eye and bone health | |
| US20190246679A1 (en) | Fortified Micronutrient Food and Beverage Additive | |
| Soriano‐Santos | Chemical composition and nutritional content of raw poultry meat | |
| AU785230B2 (en) | Egg and feed ration for producing egg | |
| Graulet et al. | Vitamins in milks | |
| US20130101569A1 (en) | Hair growth stimulant | |
| Phogat et al. | Nutritional benefits of fish consumption for humans: A review | |
| US20050281889A1 (en) | Nutritional supplement for adults | |
| Bengoa et al. | Nutritional goals for health in Latin America | |
| Joshi et al. | Vitamins and minerals in the elderly | |
| Price et al. | Reference dietary requirements of vitamins in different stages of life | |
| Luna et al. | Nutritional considerations for vegetarian athletes: a narrative review | |
| Martinez et al. | Egg protein in sports nutrition | |
| Molnar et al. | 15.2 Nutrition and Energy Production | |
| Alpers et al. | General nutritional principles | |
| Young | Diet and nutrient needs in old age | |
| Achimugu et al. | Evaluation of nutrients composition of fresh and shade dried black-eyed bean (Vigna unguiculata) leaves for food | |
| Graulet | Improving the level of vitamins in milk | |
| JEFFREY | Appendix A: Notes on nutrition for obesity medicine | |
| Taibi et al. | Diet—microbiome interaction in colorectal cancer: a potentially discriminatory role for Fusobacterium nucleatum |